304 related articles for article (PubMed ID: 2646470)
1. Prevalence of cytoplasmatic islet cell antibodies and insulin autoantibodies is increased in subjects with genetically defined high risk for insulin-dependent diabetes mellitus.
Kuglin B; Bertrams J; Linke C; Gries FA; Kolb H
Klin Wochenschr; 1989 Jan; 67(2):66-73. PubMed ID: 2646470
[TBL] [Abstract][Full Text] [Related]
2. Influence of age on the associations among insulin autoantibodies, islet cell antibodies, and HLA DAQ1*0301-DQB1*0302 in siblings of patients with type 1 (insulin-dependent) diabetes mellitus. Belgian Diabetes Registry.
Gorus FK; Vandewalle CL; Dorchy H; Van Crombrugge P; Schuit FC; Pipeleers DG
J Clin Endocrinol Metab; 1994 May; 78(5):1172-8. PubMed ID: 8175975
[TBL] [Abstract][Full Text] [Related]
3. Islet cell and insulin autoantibodies in subjects at high risk for development of type 1 (insulin-dependent) diabetes mellitus: the Lyon family study.
Thivolet C; Beaufrére B; Bétuel H; Gebuhrer L; Chatelain P; Durand A; Tourniaire J; François R
Diabetologia; 1988 Oct; 31(10):741-6. PubMed ID: 3071483
[TBL] [Abstract][Full Text] [Related]
4. Relationship between serum insulin autoantibodies, islet cell antibodies and Coxsackie-B4 and mumps virus-specific antibodies at the clinical manifestation of type 1 (insulin-dependent) diabetes.
Karjalainen J; Knip M; Hyöty H; Leinikki P; Ilonen J; Käär ML; Akerblom HK
Diabetologia; 1988 Mar; 31(3):146-52. PubMed ID: 3286341
[TBL] [Abstract][Full Text] [Related]
5. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
[TBL] [Abstract][Full Text] [Related]
6. Proinsulin autoantibodies: association with type I diabetes but not with islet cell antibodies, insulin autoantibodies or HLA-DR type.
Kuglin B; Halder B; Bertrams J; Grüneklee D; Gries FA; Kolb H
J Autoimmun; 1990 Oct; 3(5):573-7. PubMed ID: 2252525
[TBL] [Abstract][Full Text] [Related]
7. Islet cell-specific autoantibodies in children with insulin-dependent diabetes mellitus and their siblings at clinical manifestation of the disease. Childhood Diabetes in Finland Study Group.
Vähäsalo P; Knip M; Karjalainen J; Tuomilehto-Wolf E; Lounamaa R; Akerblom HK
Eur J Endocrinol; 1996 Dec; 135(6):689-95. PubMed ID: 9025714
[TBL] [Abstract][Full Text] [Related]
8. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry.
Gorus FK; Goubert P; Semakula C; Vandewalle CL; De Schepper J; Scheen A; Christie MR; Pipeleers DG
Diabetologia; 1997 Jan; 40(1):95-9. PubMed ID: 9028724
[TBL] [Abstract][Full Text] [Related]
9. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease.
Honeyman MC; Harrison LC; Drummond B; Colman PG; Tait BD
Mol Med; 1995 Jul; 1(5):576-82. PubMed ID: 8529124
[TBL] [Abstract][Full Text] [Related]
10. Combined analysis of islet cell antibodies which cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in subjects at risk for IDDM.
Chaillous L; Delamaire M; Elmansour A; Maugendre D; Rohmer V; Joseph MG; Lecomte P; Limal JM; Charbonnel B; Allannic H
Diabetologia; 1994 May; 37(5):491-9. PubMed ID: 8056187
[TBL] [Abstract][Full Text] [Related]
11. Do glutamic acid decarboxylase antibodies improve the prediction of IDDM in first-degree relatives at risk for IDDM?
Schmidli RS; Colman PG; Harrison LC
J Autoimmun; 1994 Dec; 7(6):873-9. PubMed ID: 7888043
[TBL] [Abstract][Full Text] [Related]
12. Detection of insulin autoantibodies using an ELISA technique in first-degree relatives of IDDM patients and in autoimmune patients.
Zancheta R; Russo V; Presotto F; Magrin L; Pedini B; Betterle C
Diabetes Res; 1987 Dec; 6(4):189-94. PubMed ID: 3447812
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to proinsulin and insulin as predictive markers of type 1 diabetes.
Kuglin B; Rjasanowski I; Bertrams J; Gries FA; Kolb H; Michaelis D
Diabet Med; 1990 May; 7(4):310-4. PubMed ID: 2140083
[TBL] [Abstract][Full Text] [Related]
14. The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.
Jaeger C; Hatziagelaki E; Stroedter A; Becker F; Scherer S; Petzoldt R; Federlin K; Bretzel RG
Exp Clin Endocrinol Diabetes; 1999; 107(8):496-505. PubMed ID: 10612480
[TBL] [Abstract][Full Text] [Related]
15. Correlation between islet cell antibodies and anti-cytomegalovirus IgM and IgG antibodies in healthy first-degree relatives of type 1 (insulin-dependent) diabetic patients.
Nicoletti F; Scalia G; Lunetta M; Condorelli F; Di Mauro M; Barcellini W; Stracuzzi S; Pagano M; Meroni PL
Clin Immunol Immunopathol; 1990 Apr; 55(1):139-47. PubMed ID: 2155076
[TBL] [Abstract][Full Text] [Related]
16. Prediction of type 1 diabetes.
Seidel D; Ziegler AG
Horm Res; 1996; 45 Suppl 1():36-9. PubMed ID: 8805028
[TBL] [Abstract][Full Text] [Related]
17. Associations of anti-GAD antibodies with islet cell antibodies and insulin autoantibodies in first-degree relatives of type I diabetic patients.
Roll U; Christie MR; Standl E; Ziegler AG
Diabetes; 1994 Jan; 43(1):154-60. PubMed ID: 8262311
[TBL] [Abstract][Full Text] [Related]
18. Islet cell antibodies (ICA), insulin autoantibodies (IAA), islet cell surface antibodies (ICSA) and C-peptide in 1031 school children in a population with a high background incidence of IDDM.
Samuelsson U; Ludvigsson J; Sundkvist G
Diabetes Res Clin Pract; 1994 Dec; 26(3):155-62. PubMed ID: 7736895
[TBL] [Abstract][Full Text] [Related]
19. HLA-associated insulin autoantibody formation in newly diagnosed type I diabetic patients.
Ziegler AG; Standl E; Albert E; Mehnert H
Diabetes; 1991 Sep; 40(9):1146-9. PubMed ID: 1936622
[TBL] [Abstract][Full Text] [Related]
20. Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+ relatives: the ICARUS data set. Islet Cell Antibody Register Users Study.
Bingley PJ
Diabetes; 1996 Dec; 45(12):1720-8. PubMed ID: 8922357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
